These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11402297

  • 1. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, Martino G.
    Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
    [Abstract] [Full Text] [Related]

  • 2. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
    Martino G, Poliani PL, Furlan R, Marconi P, Glorioso JC, Adorini L, Comi G.
    J Neuroimmunol; 2000 Jul 24; 107(2):184-90. PubMed ID: 10854655
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
    Furlan R, Poliani PL, Galbiati F, Bergami A, Grimaldi LM, Comi G, Adorini L, Martino G.
    Hum Gene Ther; 1998 Nov 20; 9(17):2605-17. PubMed ID: 9853527
    [Abstract] [Full Text] [Related]

  • 4. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
    Poliani PL, Brok H, Furlan R, Ruffini F, Bergami A, Desina G, Marconi PC, Rovaris M, Uccelli A, Glorioso JC, Penna G, Adorini L, Comi G, 't Hart B, Martino G.
    Hum Gene Ther; 2001 May 20; 12(8):905-20. PubMed ID: 11387056
    [Abstract] [Full Text] [Related]

  • 5. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R, Bergami A, Brambilla E, Butti E, De Simoni MG, Campagnoli M, Marconi P, Comi G, Martino G.
    Gene Ther; 2007 Jan 20; 14(1):93-8. PubMed ID: 16929354
    [Abstract] [Full Text] [Related]

  • 6. Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.
    Martino G, Poliani PL, Marconi PC, Comi G, Furlan R.
    Gene Ther; 2000 Jul 20; 7(13):1087-93. PubMed ID: 10918474
    [Abstract] [Full Text] [Related]

  • 7. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, Franciotta DM, Penna G, Comi G, Adorini L, Martino G.
    J Immunol; 2001 Aug 01; 167(3):1821-9. PubMed ID: 11466408
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glorioso JC, Comi G, Martino G.
    Gene Ther; 2001 Aug 01; 8(16):1207-13. PubMed ID: 11509953
    [Abstract] [Full Text] [Related]

  • 9. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M.
    J Neurol Sci; 2014 May 15; 340(1-2):117-22. PubMed ID: 24655735
    [Abstract] [Full Text] [Related]

  • 10. A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.
    Nygårdas M, Paavilainen H, Müther N, Nagel CH, Röyttä M, Sodeik B, Hukkanen V.
    PLoS One; 2013 May 15; 8(5):e64200. PubMed ID: 23700462
    [Abstract] [Full Text] [Related]

  • 11. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1.
    Kennedy KJ, Strieter RM, Kunkel SL, Lukacs NW, Karpus WJ.
    J Neuroimmunol; 1998 Dec 01; 92(1-2):98-108. PubMed ID: 9916884
    [Abstract] [Full Text] [Related]

  • 12. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system.
    Rajan AJ, Asensio VC, Campbell IL, Brosnan CF.
    J Immunol; 2000 Feb 15; 164(4):2120-30. PubMed ID: 10657666
    [Abstract] [Full Text] [Related]

  • 13. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS, Gonçalves ED, Pedroso GS, Farias HR, Junqueira SC, Marcon R, Tuon T, Cola M, Silveira PCL, Santos AR, Calixto JB, Souza CT, de Pinho RA, Dutra RC.
    Mol Neurobiol; 2017 Aug 15; 54(6):4723-4737. PubMed ID: 27447807
    [Abstract] [Full Text] [Related]

  • 14. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 15. Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5.
    Nygårdas M, Aspelin C, Paavilainen H, Röyttä M, Waris M, Hukkanen V.
    Gene Ther; 2011 Jul 01; 18(7):646-55. PubMed ID: 21326329
    [Abstract] [Full Text] [Related]

  • 16. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.
    Yan Y, Ding X, Li K, Ciric B, Wu S, Xu H, Gran B, Rostami A, Zhang GX.
    Mol Ther; 2012 Jul 01; 20(7):1338-48. PubMed ID: 22434134
    [Abstract] [Full Text] [Related]

  • 17. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.
    Cua DJ, Hutchins B, LaFace DM, Stohlman SA, Coffman RL.
    J Immunol; 2001 Jan 01; 166(1):602-8. PubMed ID: 11123343
    [Abstract] [Full Text] [Related]

  • 18. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse.
    Nygårdas PT, Määttä JA, Hinkkanen AE.
    Eur J Immunol; 2000 Jul 01; 30(7):1911-8. PubMed ID: 10940880
    [Abstract] [Full Text] [Related]

  • 19. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.
    Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, Fitzgerald DC, Shindler KS, Rostami A.
    J Neuroinflammation; 2009 Apr 28; 6():14. PubMed ID: 19400960
    [Abstract] [Full Text] [Related]

  • 20. CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis.
    Ansari MA, Nadeem A, Attia SM, Bakheet SA, Shahid M, Rehman MU, Alanazi MM, Alhamed AS, Ibrahim KE, Albekairi NA, Ahmad SF.
    Immunobiology; 2022 Sep 28; 227(5):152245. PubMed ID: 35868215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.